• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD146启动子多态性(rs3923594)与中国人群透明细胞肾细胞癌复发相关。

CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.

作者信息

Feng Gang, Huang Hou-Bao, Ye Xiao-Bing, Zhang Peng, Huang Jian-Jun, Huang Li-Zhu, Cheng Long, Pu Chun, Li Guorong

机构信息

Clinical Laboratory, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China.

Department of Urology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui 241001, China.

出版信息

Dis Markers. 2017;2017:2543059. doi: 10.1155/2017/2543059. Epub 2017 May 24.

DOI:10.1155/2017/2543059
PMID:28626293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5463157/
Abstract

INTRODUCTION

CD146 is a membrane signal receptor in tumor-induced angiogenesis. However, limited studies have focused on the CD146 promoter polymorphisms in clear cell renal cell carcinoma (ccRCC).

PURPOSE

The purpose of this study was to investigate the association between polymorphisms located in the promoter region of the CD146 gene and characteristics of ccRCC in Chinese population. The association between the CD146 promoter polymorphisms and CD146 expression was also investigated in ccRCC.

MATERIALS AND METHODS

A total of 600 samples including 300 ccRCC patients and 300 healthy controls were collected for analysis of the CD146 promoter polymorphisms by direct sequence. The CD146 expressions were measured by qRT-PCR.

RESULTS

We had not found any significant differences in genotypic and allelic frequencies of CD146 promoter polymorphisms between ccRCC patients and controls. The rs3923594 was associated with stage and metastasis (300 cases) and recurrence (263 cases) of ccRCC in Chinese population. A significant association was also observed between the rs3923594 and CD146 expression (227 cases) in ccRCC.

CONCLUSIONS

CD146 promoter polymorphisms were not associated with the risk of ccRCC in Chinese population. The rs3923594 was an independent predictor of recurrence in Chinese patients with localized ccRCC.

摘要

引言

CD146是肿瘤诱导血管生成中的一种膜信号受体。然而,针对透明细胞肾细胞癌(ccRCC)中CD146启动子多态性的研究有限。

目的

本研究旨在探讨中国人群中CD146基因启动子区域多态性与ccRCC特征之间的关联。同时也研究了ccRCC中CD146启动子多态性与CD146表达之间的关联。

材料与方法

共收集600份样本,包括300例ccRCC患者和300例健康对照,通过直接测序分析CD146启动子多态性。采用qRT-PCR检测CD146表达。

结果

我们未发现ccRCC患者与对照之间CD146启动子多态性的基因型和等位基因频率存在任何显著差异。rs3923594与中国人群ccRCC的分期和转移(300例)及复发(263例)相关。在ccRCC中,rs3923594与CD146表达(227例)之间也观察到显著关联。

结论

在中国人群中,CD146启动子多态性与ccRCC风险无关。rs3923594是中国局限性ccRCC患者复发的独立预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28e2/5463157/7392fde0ec58/DM2017-2543059.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28e2/5463157/66dda1adf24f/DM2017-2543059.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28e2/5463157/7392fde0ec58/DM2017-2543059.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28e2/5463157/66dda1adf24f/DM2017-2543059.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28e2/5463157/7392fde0ec58/DM2017-2543059.002.jpg

相似文献

1
CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population.CD146启动子多态性(rs3923594)与中国人群透明细胞肾细胞癌复发相关。
Dis Markers. 2017;2017:2543059. doi: 10.1155/2017/2543059. Epub 2017 May 24.
2
CD146 gene expression in clear cell renal cell carcinoma: a potential marker for prediction of early recurrence after nephrectomy.CD146 基因在肾透明细胞癌中的表达:预测肾切除术后早期复发的潜在标志物。
Int Urol Nephrol. 2012 Dec;44(6):1663-9. doi: 10.1007/s11255-012-0255-4. Epub 2012 Jul 25.
3
DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.SLC16A3 启动子的 DNA 甲基化调控人乳酸转运体 MCT4 在肾细胞癌中的表达,影响临床结局。
Clin Cancer Res. 2013 Sep 15;19(18):5170-81. doi: 10.1158/1078-0432.CCR-13-1180. Epub 2013 Jul 23.
4
XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.XRCC3基因Thr241Met多态性与XPD基因Lys751Gln多态性及透明细胞肾细胞癌风险
Cancer Biomark. 2016;16(2):211-7. doi: 10.3233/CBM-150558.
5
Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.亚甲基四氢叶酸还原酶(MTHFR)基因 C677T、A1298C 和 G1793A 多态性:与男性透明细胞肾细胞癌风险和肿瘤行为的关联。
Clin Oncol (R Coll Radiol). 2012 May;24(4):269-81. doi: 10.1016/j.clon.2011.03.005. Epub 2011 Apr 13.
6
Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.FOXO3a 的下调促进肿瘤转移,并与透明细胞肾细胞癌患者的无转移生存相关。
Clin Cancer Res. 2014 Apr 1;20(7):1779-90. doi: 10.1158/1078-0432.CCR-13-1687. Epub 2014 Jan 31.
7
Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma.可溶性 CD146 是透明细胞肾细胞癌不良预后和舒尼替尼疗效的预测标志物。
Theranostics. 2018 Mar 28;8(9):2447-2458. doi: 10.7150/thno.23002. eCollection 2018.
8
PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.纤溶酶原激活物抑制因子-1 在肾透明细胞癌中的表达及其启动子 4G/5G 多态性的调控。
J Clin Pathol. 2011 Oct;64(10):893-7. doi: 10.1136/jclinpath-2011-200182. Epub 2011 Jul 1.
9
Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.肿瘤抑制基因谷胱甘肽过氧化物酶3通过启动子高甲基化频繁发生表观遗传抑制及其在肾透明细胞癌中的临床意义
Int J Mol Sci. 2015 May 11;16(5):10636-49. doi: 10.3390/ijms160510636.
10
Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.胰岛素样生长因子结合蛋白 3(IGFBP-3)基因变异与肾细胞癌有关。
BJU Int. 2011 Sep;108(5):762-70. doi: 10.1111/j.1464-410X.2010.10017.x. Epub 2011 Feb 14.

引用本文的文献

1
Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors.针对CD146的治疗性和诊断性抗体:关于其在肿瘤检测和治疗潜力方面的三十年研究
Antibodies (Basel). 2017 Nov 5;6(4):17. doi: 10.3390/antib6040017.

本文引用的文献

1
Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.波兰人群中3'附近基因BTLA多态性与肾细胞癌风险的关联
Urol Oncol. 2016 Sep;34(9):419.e13-9. doi: 10.1016/j.urolonc.2016.04.010. Epub 2016 May 24.
2
Clinicopathologica Epidemiological Characteristics and Change Tendencies of Renal Cell Carcinoma in Shanxi Province of China from 2005 to 2014.2005年至2014年中国山西省肾细胞癌的临床病理流行病学特征及变化趋势
PLoS One. 2015 Dec 3;10(12):e0144246. doi: 10.1371/journal.pone.0144246. eCollection 2015.
3
Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.
磁共振成像作为肾细胞癌的生物标志物
Dis Markers. 2015;2015:648495. doi: 10.1155/2015/648495. Epub 2015 Nov 1.
4
CYP3A5 and ABCB1 polymorphisms as predictors for sunitinib outcome in metastatic renal cell carcinoma.CYP3A5 和 ABCB1 多态性作为转移性肾细胞癌舒尼替尼疗效的预测因子。
Eur Urol. 2015 Oct;68(4):621-9. doi: 10.1016/j.eururo.2015.04.018. Epub 2015 Apr 27.
5
CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development.CD146作为一种新的netrin-1受体,在促进血管生成和血管发育中发挥作用。
Cell Res. 2015 Mar;25(3):275-87. doi: 10.1038/cr.2015.15. Epub 2015 Feb 6.
6
Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients.血管内皮生长因子多态性对肾细胞癌患者临床结局的预测价值。
Oncol Lett. 2015 Feb;9(2):651-656. doi: 10.3892/ol.2014.2798. Epub 2014 Dec 12.
7
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
8
Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.GSTM3 启动子的遗传变异通过降低基因表达水平,赋予了肾细胞癌的发病风险和预后不良。
Br J Cancer. 2013 Dec 10;109(12):3105-15. doi: 10.1038/bjc.2013.669. Epub 2013 Oct 24.
9
Functional TLR5 genetic variants affect human colorectal cancer survival.功能性 TLR5 基因变异影响人类结直肠癌的生存。
Cancer Res. 2013 Dec 15;73(24):7232-42. doi: 10.1158/0008-5472.CAN-13-1746. Epub 2013 Oct 23.
10
Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma.外周血CD133 mRNA定量在透明细胞肾细胞癌患者转移识别及复发预测中的应用
Urol Oncol. 2014 Jan;32(1):44.e9-14. doi: 10.1016/j.urolonc.2013.06.003. Epub 2013 Sep 17.